Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation

Abstract

This is the first published evidence-based guideline using the AGREE II framework and GRADE methods for the use of metformin to prevent AIWG incorporating recommendations for co-commencement. Implementation and evaluation of the guideline will be supported by a shared decision-making package and assessment of barriers and facilitators to implementation.